Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2-chloro-4-phenoxyphenyl)(4-(((3r,6s)-6-(hydroxymethyl)tetrahydro-2h-pyran-3-yl)amino)-7h-pyrrolo(2,3-d)pyrimidin-5-yl)methanone
2. Arq-531
3. Arq531
1. Arq 531
2. 2095393-15-8
3. Arq-531
4. Nemtabrutinib
5. Jtz51lixn4
6. Arq531
7. Mk1026
8. Mk-1026
9. (2-chloro-4-phenoxyphenyl)-[4-[[(3r,6s)-6-(hydroxymethyl)oxan-3-yl]amino]-7h-pyrrolo[2,3-d]pyrimidin-5-yl]methanone
10. (2-chloro-4-phenoxyphenyl)(4-(((3r,6s)-6-(hydroxymethyl)tetrahydro-2h-pyran-3-yl)amino)-7h-pyrrolo(2,3-d)pyrimidin-5-yl)methanone
11. 1,5-anhydro-2-{[5-(2-chloro-4-phenoxybenzene-1-carbonyl)-7h-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-2,3,4-trideoxy-d-erythro-hexitol
12. Arqule 531
13. Unii-jtz51lixn4
14. Nemtabrutinib [inn]
15. Nemtabrutinib [who-dd]
16. Chembl4756476
17. Schembl18756744
18. Schembl18770934
19. Gtpl11413
20. Arq531; Arq 531
21. Bdbm499811
22. Bcp29029
23. Ex-a2727
24. Vid39315
25. Mfcd31692379
26. Nsc830201
27. S8711
28. At10312
29. Ccg-269533
30. Nsc-830201
31. Us11020398, Compound I-123
32. Ac-36883
33. As-79762
34. Hy-112215
35. Cs-0044154
36. (2-chloro-4-phenoxyphenyl)(4-(((3r,6s)-6-(hydroxymethyl)tetrahydro-2h-pyran-3-yl)amino)-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methanone
37. D-erythro-hexitol, 1,5-anhydro-2-((5-(2-chloro-4-phenoxybenzoyl)-7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)-2,3,4-trideoxy-
38. Hra
Molecular Weight | 478.9 g/mol |
---|---|
Molecular Formula | C25H23ClN4O4 |
XLogP3 | 4.3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 7 |
Exact Mass | 478.1407829 g/mol |
Monoisotopic Mass | 478.1407829 g/mol |
Topological Polar Surface Area | 109 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 681 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A ARQ 531 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ARQ 531, including repackagers and relabelers. The FDA regulates ARQ 531 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ARQ 531 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A ARQ 531 supplier is an individual or a company that provides ARQ 531 active pharmaceutical ingredient (API) or ARQ 531 finished formulations upon request. The ARQ 531 suppliers may include ARQ 531 API manufacturers, exporters, distributors and traders.
ARQ 531 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ARQ 531 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ARQ 531 GMP manufacturer or ARQ 531 GMP API supplier for your needs.
A ARQ 531 CoA (Certificate of Analysis) is a formal document that attests to ARQ 531's compliance with ARQ 531 specifications and serves as a tool for batch-level quality control.
ARQ 531 CoA mostly includes findings from lab analyses of a specific batch. For each ARQ 531 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ARQ 531 may be tested according to a variety of international standards, such as European Pharmacopoeia (ARQ 531 EP), ARQ 531 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ARQ 531 USP).
LOOKING FOR A SUPPLIER?